PLUS1
8,537.00
-123.00 (-1.42%)
-123.00 (-1.42%)
Upgrade to Real-Time
Market Closed
Best deals to access real time data! |
|
Real-time Level 1 for London Stock Exchange
Monthly Subscription
for only
$29.56
|
|
London Stock Exchange Level 2
Monthly Subscription
for only
$77.61
|
|
Real-time London Stock Exchange & FTSE
Monthly Subscription
for only
$88.69
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type | ISIN | Company Description |
|---|---|---|---|---|---|
| Astrazeneca Plc | AZN | London | Ordinary Share | GB0009895292 | ORD SHS $0.25 |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -123.00 | -1.42% | 8,537.00 | 8,452.00 | 8,606.00 | 8,590.00 | 8,660.00 | 11:35:20 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 8,535.00 | 8,536.00 | 1.00 | 0.01% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 10,172 | 1,749,921 | 8,520.01p | 149,093,523p | - | 5,871.00 - 9,333.00 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 12:48:26 | O | 3,296 | 8,529.121p | GBX |
| Industry Sector |
|---|
| PHARMACEUTICALS & BIOTECHNOLOGY |
Astrazeneca Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 110.97Bp | - | - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Astrazeneca News
| Date | Time | Source | News Article |
|---|---|---|---|
| 7/01/2020 | 10:00 | UK Regulatory (RNS & others) | AstraZeneca PLC Total Voting Rights |
| 6/30/2020 | 10:00 | UK Regulatory (RNS & others) | AstraZeneca PLC Director/PDMR Shareholding |
| 6/30/2020 | 04:24 | Alliance News |  AstraZeneca Drug Selumetinib Gets Orphan Drug Designation In.. |
| 6/30/2020 | 02:00 | UK Regulatory (RNS & others) | AstraZeneca PLC Selumetinib granted Japan orphan drug.. |
| 6/21/2020 | 19:15 | PR Newswire (US) | Ascentage Pharma Enters Clinical Collaboration to Evaluate.. |
| 6/17/2020 | 10:03 | UK Regulatory (RNS & others) | AstraZeneca PLC Holding(s) in Company |
| 6/17/2020 | 10:00 | UK Regulatory (RNS & others) | AstraZeneca PLC Holding(s) in Company |
Astrazeneca Discussion Forums - AZN
| Date | Time | Comments | Title |
|---|---|---|---|
| 6/15/2020 | 03:44 | - | Goodwill moving us up in premarket? I |
| 6/10/2020 | 13:06 | - | The U.S, government this summer plans decisive Phase |
| 6/07/2020 | 10:22 | - | AstraZeneca approached Gilead about potential merger: |
| 6/06/2020 | 10:25 | - | “It’s possible that treatment with so-called type-1 interferon |
| 5/27/2020 | 07:23 | - | Where is the bottom? |
| 5/26/2020 | 09:03 | - | From The Street Quant Ratings : RECOMMENDATION We |
| 5/22/2020 | 11:57 | - | On the way up..... |
| 5/22/2020 | 07:16 | - | https://www.statnews.com/2020/05/21/coronavirus-hijacks-cells-in-unique-ways/ T |
| 5/04/2020 | 09:57 | - | yup. Been looking at options..... |
| 5/04/2020 | 09:46 | - | I just bought a position. Have you heard about |
Historical AZN Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 8,509.00 | 8,667.00 | 8,347.00 | 8,506.95 | 1,677,988 | 28.00 | 0.33% |
| 1 Month | 8,200.00 | 8,667.00 | 8,101.00 | 8,427.47 | 2,250,849 | 337.00 | 4.11% |
| 3 Months | 7,477.00 | 9,333.00 | 7,474.00 | 8,417.94 | 2,493,034 | 1,060.00 | 14.18% |
| 6 Months | 7,608.00 | 9,333.00 | 5,871.00 | 7,717.13 | 2,586,101 | 929.00 | 12.21% |
| 1 Year | 6,460.00 | 9,333.00 | 5,871.00 | 7,468.28 | 2,364,047 | 2,077.00 | 32.15% |
| 3 Years | 5,100.00 | 9,333.00 | 4,260.00 | 6,147.15 | 2,298,781 | 3,437.00 | 67.39% |
| 5 Years | 4,179.50 | 9,333.00 | 3,680.00 | 5,408.05 | 2,451,005 | 4,357.50 | 104.26% |
